Posts filtered by tags: Turing Pharmaceuticals[x]


 

Despite Drug Industry Claims, Higher List Prices Do Mean Higher Out-of-Pocket Costs for Many Patients

New research suggests that as the list price of brand name drugs rise, so do out-of-pocket medical costs for these drugs—at least for some patients. This is counter to a common industry claim that patients aren’t affected by list price increases. The study found a link between list prices rising and out-of-pocket…Read more...
Tags: Health, Science, Medicare, Martin Shkreli, Daraprim, Turing Pharmaceuticals, Pharmacy, Pharmaceutical Industry, Drug Pricing, Prescription drug, Health Sciences, U S Healthcare, Healthcare Reform In The United States, Pharmaceuticals Policy, Health Medical Pharma, Benjamin Rome


Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

Last month, Gilead Sciences CEO Daniel O’Day announced plans to introduce 10 “transformative medicines” over the next 10 years. Acquisitions would help meet that ambitious goal, and this week Gilead announced one of them: a nearly $5 billion deal for cancer immunotherapy developer Forty Seven.Forty Seven’s lead CD47-blocking drug—the company is named after the signaling molecule— is being tested in combination with chemotherapy as a treatment for blood cancers, although O’Day noted it could pot...
Tags: Deals, Startups, Ipo, Cancer, Trends, Venture Capital, M&a, Astrazeneca, Fda, National, Novartis, Allergan, Abbvie, Biotech, Stock Market, Nasdaq


New York and Federal Authorities Sue ‘Pharma Bro’ Martin Shkreli for ‘Scheme’ to Keep Drug Price Up

NEW YORK — State and federal authorities sued imprisoned drug entrepreneur Martin Shkreli on Monday over business tactics that helped make him the bad-boy face of profiteering in the pharmaceuticals industry, seeking to bar the so-called “Pharma Bro” from the industry for life. Shkreli became infamous in 2015 for engineering a huge price hike for a long-existing medication for a sometimes life-threatening parasitic infection. Monday’s lawsuit, filed by the New York attorney general’s office...
Tags: New York, News, Uncategorized, Federal Trade Commission, Ftc, Martin Shkreli, Daraprim, Turing Pharmaceuticals, Shkreli, Letitia James, Onetime, Pharma Bros, Phoenixus AG, Federal Authorities Sue ` Pharma Bro, Vyera Pharmaceuticals LLC, Gail Levine


THE OBAMACARE DECADE: Top healthcare leaders who worked for Trump, Obama, and Bush share the biggest healthcare developments of the 2010s

The 2010s were a decade defined by massive advancements in biology and health.  The US saw a generational shift in health policy, thanks to the Affordable Care Act. At the same time, genomics and the use of new treatments that harness the body's immune system changed the way we treat cancer.  The Business Insider healthcare team looked back at our reporting and turned to the experts to break out the decade's biggest healthcare developments. Subscribe to Dispensed, Business Insider's weekly hea...
Tags: Supreme Court, Obamacare, Congress, Senate, US, America, Barack Obama, Trends, Merck, Canada, Hillary Clinton, United States, House, Jimmy Carter, Cigna, Food And Drug Administration


Martin Shkreli's appeal denied

Martin Shkreli, trollish ex-CEO of Turing Pharmaceuticals, who became infamous in 2015 when he jacked up the price of an HIV medication 5,000%, received some unpleasant news today, reports CNBC. The Supreme Court rejected his request for an appeal of his securities fraud conviction. That means he's going to have to serve the rest of his 7-year sentence and forfeit his $6.4 million fine. While his fraud case was pending, Shkreli won the hearts of Trumpsters when he put a bounty on a strand of hai...
Tags: Post, News, Hillary Clinton, Trolls, Fraudsters, Martin Shkreli, Turing Pharmaceuticals, Pharma Bro, Shkreli, House Committee, Felons, CNBC The Supreme Court


Martin Shkreli Is Reportedly in Solitary Confinement After Trying to Run a Company From Prison

So-called “pharma bro” Martin Shkreli earned the eternal ire of the public when he was the CEO of a company called Turing Pharmaceuticals, which he had buy up the rights to and jack up the price of life-saving drug Daraprim from $13.50 to $750 a pill. He then landed himself a seven-year prison sentence in 2018 on…Read more...
Tags: Science, Technology, Prison, Courts, Pharmaceuticals, Martin Shkreli, Turing Pharmaceuticals, Pharma Bro, Solitary Confinement


The 5,000% price hike that made Martin Shkreli infamous is no longer paying off (ars technica)

Enlarge / NEW YORK - AUGUST 4: Shkreli was found guilty on three of the eight counts involving securities fraud and conspiracy to commit securities and wire fraud. (credit: Getty | Drew Angerer) Martin Shkreli’s former pharmaceutical company lost more than $1 million in the first quarter of 2018 amid waning sales of the drug made famous by Shkreli’s more than 5,000-percent price increase. That’s according to financial documents recently reviewed by Stat. Vyera Pharmaceuticals, formerly known a...
Tags: News, Martin Shkreli, Turing Pharmaceuticals, Beth Mole, Shkreli, Drew Angerer Martin Shkreli, Stat Vyera Pharmaceuticals, Turing Shkreli


Shkrelifreude: while Martin Shkreli rots in prison, his price-gouging pharma company is hemorrhaging money

Smirking pharma-bro Martin Shkreli first came to public attention when he hiked the price of a drug used by people with HIV from $13.50/pill to $750/pill. (more…)
Tags: Post, Business, News, Hiv, Pharma, Martin Shkreli, Daraprim, Turing Pharmaceuticals, Guillotine Watch, Phoenixus, Sic Semper Smirking Shitheads, Vyera


For shame: ‘Pharma bro’ Shkreli is in prison, but Daraprim’s price is still high

It was 2015 when Martin Shkreli, then CEO of Turing Pharmaceuticals and the notorious "pharma bro," jacked up the cost of the lifesaving drug Daraprim by 5,000 percent. Overnight, its price tag skyrocketed from $13.50 a pill to $750.
Tags: Health, Martin Shkreli, Daraprim, Turing Pharmaceuticals, ` Pharma


'Pharma Bro' Martin Shkreli sheds tears at sentencing hearing, gets 7 years in prison

Maligned "pharma bro" Marin Shkreli shed tears as he made a final plea to the judge who handed down his 7-year prison sentence in a New York courtroom on Friday afternoon for securities and wire fraud charges. SEE ALSO: Pharma Bro Martin Shkreli trolls journalists in the most menacing way Reporters for Vice, Bloomberg, and WCBS reported Shkreli's remorse for his many, many actions that have led to one of the biggest examples of schadenfreude we've seen in quite some time.  shkreli is...
Tags: New York, News, Bloomberg, Hillary Clinton, Wu Tang, Associated Press, Bernie Sanders, Martin Shkreli, Turing Pharmaceuticals, WCBS, Shkreli, Bro Martin Shkreli, Meg Tirrell, Matsumoto, Lauren Duca, Brafman


Sobbing Martin Shkreli Sentenced to 7 Years in Prison for Securities Fraud and Being an Asshole

When “pharma bro” Martin Shkreli spoke with Gizmodo back in September, he told us he wouldn’t spend a single day in prison. Turns out, he was wrong.Read more...
Tags: Crying, Science, Hiv, Wu Tang, Gizmodo, Pharma, Martin Shkreli, Daraprim, Turing Pharmaceuticals, Once Upon A Time In Shaolin, Pharma Bro, Hivaids, Septic Shock, Judge Kiyo Matsumoto, Shkreli Sentence, Sobbing


Federal prosecutors seeking (way-below-guideline) sentence of 15 years for "Pharma Bro" Martin Shkreli

As reported in this new Reuters piece, "U.S. prosecutors on Tuesday said former drug company executive Martin Shkreli should spend at least 15 years in prison after being convicted of fraud, saying his lack of remorse and respect for the law justified a long time behind bars." Here is more, with a final point stressed for commentary: The request by the Department of Justice came three days before Shkreli’s scheduled sentencing by U.S. District Judge Kiyo Matsumoto in Brooklyn federal court. Pro...
Tags: Law, Brooklyn, Hillary Clinton, Wu Tang, Department Of Justice, Martin Shkreli, Turing Pharmaceuticals, Picasso, Reuters, Bro, Shkreli, Bro Martin Shkreli, Douglas A Berman, U S District Judge Kiyo Matsumoto, Matsumoto, Brafman


"Pharma Bro" Martin Shkreli, facing decades under guidelines, seeks prison sentence of 12-18 months

As reported in this Reuters article, "Martin Shkreli, the former drug company executive convicted of defrauding investors in two hedge funds he ran, has asked a federal judge to sentence him to 12 months to 18 months in prison, much less than suggested federal guidelines."  Here is more: Shkreli, 34, has been in jail since September, when U.S. District Judge Kiyo Matsumoto revoked his bail after he offered a $5,000 bounty for a strand of Hillary Clinton’s hair in a Facebook post.  Matsumoto is ...
Tags: Facebook, Law, Cyprus, Hillary Clinton, Turing, Martin Shkreli, Turing Pharmaceuticals, Reuters, Bro, Shkreli, Bro Martin Shkreli, Retrophin, Douglas A Berman, Matsumoto, Kiyo Matsumoto, Retrophin Inc Shkreli


Company founded by Shkreli off the hook in $43M lawsuit

Vyera Pharmaceuticals, formerly known as Turing Pharmaceuticals, does not have to pay Impax Laboratories Inc $43 million in a dispute stemming from Turing founder Martin Shkreli's decision to boost by 5,000 percent the price of a drug Turing bought from Impax, a U.S. judge ruled on Friday.
Tags: Finance, Article, Turing, Martin Shkreli, Turing Pharmaceuticals, Reuters, Shkreli, FBN, Impax Laboratories Inc, Impax, Fbn/markets, FOX BUSINESS/MARKETS, FOX BUSINESS/INDUSTRIES/Health Care, Fox-business/news, A5610187-e25a-40d8-9387-ae8f602a3ae1, Vyera Pharmaceuticals


Wu-Tang clap back, dissing Martin Shkreli on new track

The jailed businessman paid $2m for the sole copy of the rap group’s album, but earned their lyrical enmity for price-gouging patients over a life-saving drugMartin Shkreli – the “Pharma bro” now in jail after putting a bounty on Hillary Clinton’s hair – received more bad news on Friday: the Wu-Tang Clan released a new track that takes a swipe at their most controversial fan.Shkreli rose to infamy as CEO of Turing Pharmaceuticals after hiking the price of a lifesaving drug, Daraprim, by 5,000%. ...
Tags: Business, Music, US news, Culture, Hillary Clinton, Pharmaceuticals industry, Wu Tang, Wu-tang Clan, Martin Shkreli, Turing Pharmaceuticals, Shkreli


You be the federal judge: what sentence for "Pharma Bro" after his fraud convictions?

As regular readers know, I enjoy following up news of a high-profile conviction by asking what sentence readers think fitting for the high-profile convicted offender.  As detailed in this MSNBC report, headlined "'Pharma bro' Martin Shkreli found guilty of 3 of 8 charges, including securities fraud," the high-profile offender this time around is a notorious pharmaceutical executive. Here are the basics about his crime: A federal jury Friday found notorious "Pharma bro" Martin Shkreli guilty of ...
Tags: Law, United States, New York Times, Msnbc, Martin Shkreli, Turing Pharmaceuticals, Evan Greebel, Bro, Martin, Shkreli, Brooklyn New York, Pharma Bro Martin Shkreli, Retrophin, Boies Schiller Flexner, Benjamin Brafman, Douglas A Berman


Who is Martin Shkreli - 'the most hated man in America'?

Martin Shkreli, the 32-year-old chief executive of Turing Pharmaceuticals, may be the most hated man in America right now.
Tags: News, America, Martin Shkreli, Turing Pharmaceuticals


Quirky Genius Allegedly Well-Versed in Fraud

Quirky Genius Allegedly Well-Versed in Fraud The post Quirky Genius Allegedly Well-Versed in Fraud appeared first on Legal Reader.
Tags: Business, Legal, Law, Jury, Entrepreneur, Management, People, Fraud, Statement, Genius, Price, Quirky, Lawyer, Chief Executive, Drug, Tag


Former Co-Worker Says Martin Shkreli “Full of Shit”

Ah to be loved and respected by your employees. That is something Martin Shkreli doesn’t have to worry about. A recent article in the New York Post suggests some co-workers think he is the anti-Christ. Now that the feds (and seemingly everyone else) is trying to take down Shkreli, it appears that some of the co-workers are willing to speak. As a leading whistleblower law firm investigating big pharma, we are always on the hunt for pharmaceutical workers willing to blow the whistle on fraud, gree...
Tags: New York Post, Taxes, Congress, US, America, United States, Martin Shkreli, Daraprim, Turing Pharmaceuticals, Martin, Shkreli, House Committee, Jane Doe, Retrophin Inc, Fraud Recovery, Brian Mahany


8 Outrageous Quotes From Martin Shkreli

The fraud trial for Martin Shkreli, the founder of Founder of Turing Pharmaceuticals, started Monday. Before that happened, the “pharma bro” gained notoriety in 2015 for raising the price of Daraprim, a drug that helps AIDS patients, from $13.50 a tablet to $750. He faced charges of using profits from Retrophin, a drug company he founded, to repay investors he also defrauded.
Tags: News, Martin Shkreli, Daraprim, Turing Pharmaceuticals, Retrophin


Martin Shkreli, Who Raised An HIV Drug 5,000 Percent, Goes To Trial, Faces 20 Years In Jail

Martin Shkreli is set to stand trial in a New York federal court Monday for security fraud. The notorious former CEO of Turing Pharmaceuticals has been accused of running a Ponzi scheme and could face up to 20 years in prison if convicted. In addition to security fraud, the 34-year-old is accused of wire fraud, conspiracy, and mismanaging money at his investment funds Elea Capital, MSMB Capital, MSMB Healthcare, as well as while CEO of Retrophin (RTRX), the pharmaceutical company he founded in 2...
Tags: New York, News, Martin Shkreli, Turing Pharmaceuticals, Elea Capital MSMB Capital MSMB Healthcare


Bail reduction for Shkreli has been denied

A federal judge on Monday rejected Martin Shkreli's bid to reduce his criminal release bail from $5 million to $2 million. The former Turing Pharmaceuticals CEO — notorious for raising the cost of an anti-infection drug by more than 5,455 percent — was charged in December 2015 with securities fraud related to his previous professional life as a hedge fund manager and leader of a different drug company, Retrophin. According to CNBC, lawyer Benjamin Brafman claimed that Shkreli "doesn't have… ...
Tags: Cnbc, Martin Shkreli, Turing Pharmaceuticals, Shkreli, Benjamin Brafman


This Pharma Company Won't Commit To Fairly Pricing A Zika Vaccine You Helped Pay For

function onPlayerReadyVidible(e){'undefined'!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if('object'==typeof commercial_video){var a='',o='m.fwsitesection='+commercial_video.site_and_category;if(a+=o,commercial_video['package']){var c='&m.fwkeyvalues=sponsorship%3D'+commercial_video['package'];a+=c}e.setAttribute('vdb_params',a)}i(e.vdb_Player)}else{var t=arguments.callee;setTimeout(function(){t(e,i)},0)}}(document.getElementById('vidible_1'),onPlayerReady...
Tags: Florida, Koss, News, Congress, Cdc, Washington, France, Senate, United States, United Kingdom, House, New York Times, Paris, Army, Medicare, National Institutes of Health


Maryland Lawmakers Approve Bill To Fight Drug Price-Gouging

function onPlayerReadyVidible(e){'undefined'!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if('object'==typeof commercial_video){var a='',o='m.fwsitesection='+commercial_video.site_and_category;if(a+=o,commercial_video['package']){var c='&m.fwkeyvalues=sponsorship%3D'+commercial_video['package'];a+=c}e.setAttribute('vdb_params',a)}i(e.vdb_Player)}else{var t=arguments.callee;setTimeout(function(){t(e,i)},0)}}(document.getElementById('vidible_1'),onPlayerReady...
Tags: News, Maryland, Tennessee, Medicaid, Rhode Island, Huffington Post, Turing Pharmaceuticals, Erin Schumaker, Larry Hogan, Brian Frosh, Ian Simpson, Frosh, Lisa Shumaker, Daniel Trotta, Chester Davis Jr, Association for Accessible Medicines


Martin Shkreli keeps buying up the personal domain names of journalists who write about him

Former pharmaceutical executive Martin Shkreli is trolling journalists who have written about him by purchasing the internet domains associated with their names. A recent look at the domains bought by Shkreli noted that he bought domain names for at least 10 people in the past several months, 5 of whom work in media and have written and tweeted about the former Turing Pharmaceuticals founder. Shkreli, of course, sparked national outrage when he raised the price  by 5,000%  for a drug used to com...
Tags: Facebook, Steve Jobs, Trends, Bloomberg, Capitol Hill, Gizmodo, Martin Shkreli, Turing Pharmaceuticals, Noisey, Shkreli, Teen Vogue, Witmer, Dylan Scott, Max Nisen, Kellyanne Conway, Lauren Duca


Thanks, Martin Shkreli, for the Dumbest Advice Ever on Drug Pricing

Martin Shkreli is the epitome of everything the American consumer loves to hate.Shkreli, formerly the CEO of privately held Turing Pharmaceuticals, found himself in the spotlight in Sept. 2015 after his company acquired the rights to Daraprim, a life-saving, infection-fighting drug for AIDS and cancer patients. Despite not changing the formulation of Daraprim (which happened to be more than six decades old), or altering its manufacturing process one iota, Shkreli raised its per-pill price from $...
Tags: Finance, Health Care, Sean Williams, Martin Shkreli, Daraprim, Turing Pharmaceuticals, Shkreli, Getty Images Continue, Gild, Cb3f3954-f4a8-11e6-a027-0050569d4be0


Fire alarm, protests disrupt ex-pharma exec Shkreli's talk

CAMBRIDGE, Mass. (AP) " A fire alarm and student protests have disrupted indicted former pharmaceutical executive Martin Shkreli's (SHKREL'-eez) appearance at Harvard University.The former CEO of Turing Pharmaceuticals was invited... [Author: [email protected]]
Tags: Business, Harvard University, Martin Shkreli, Turing Pharmaceuticals, Shkreli, Cambridge Mass


Harvard students protest ex-pharma exec Shkreli's talk

CAMBRIDGE, Mass. (AP) " Harvard students are protesting a campus appearance by indicted former pharmaceutical executive Martin Shkreli.The former CEO of Turing Pharmaceuticals is slated to talk about investing at a Wednesday night... [Author: [email protected]]
Tags: Business, Harvard, Martin Shkreli, Turing Pharmaceuticals, Shkreli, CAMBRIDGE Mass AP Harvard


Ex-drug company CEO Martin Shkreli to speak at Harvard

CAMBRIDGE, Mass. (AP) — Controversial former pharmaceutical executive Martin Shkreli is set to speak at Harvard while out on bail awaiting his federal securities fraud trial. The former CEO of Turing Pharmaceuticals is expected to talk about investing and health care at an event organized by the Harvard Financial Analysts Club. The talk on Wednesday […]
Tags: News, Ap, Harvard, Martin Shkreli, Turing Pharmaceuticals, Cambridge Mass, Nation & World, Harvard Financial Analysts Club


'Pharma Bro' Martin Shkreli banned from Twitter

Martin Shkreli, the former Turing Pharmaceuticals executive who became known as "Pharma Bro" after he dramatically hiked the price of a drug, was suspended from Twitter on Sunday afternoon. A person at Twitter who is familiar with... [Author: [email protected]]
Tags: Business, Martin Shkreli, Turing Pharmaceuticals, Pharma Bro, Pharma Bro Martin Shkreli